NFKB1 and malignant colon neoplasm: In addition, AG also downregulated p-NF-κB, NF-κBP65, p-IκBα, TNF-α, and IL-6 (Yang et al., 2021), indicating that targeting NF-κB signaling might be one of the mechanisms of AG in colon cancer therapy.